Novocure (NVCR) Tops Q1 EPS by 14c
Tweet
Share
E-mailGet Alerts NVCR Hot Sheet
Join SI Premium – FREE
Novocure (NASDAQ: NVCR) reported Q1 EPS of ($0.04), $0.14 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $137.5 million versus the consensus estimate of $134.08 million.
For earnings history and earnings-related data on Novocure (NVCR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
- bioAffinity (BIAF) Tops Q2 EPS by 146c
- Minerva Neurosciences (NERV) Tops Q2 EPS by 5c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
